Beam Therapeutics
BEAM
BEAM
157 hedge funds and large institutions have $3.01B invested in Beam Therapeutics in 2020 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 44 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
6.65% more ownership
Funds ownership: 57.04% → 63.69% (+6.6%)
56% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $32.8M
Holders
157
Holding in Top 10
5
Calls
$14.4M
Puts
$32.8M
Top Buyers
| 1 | +$92.4M | |
| 2 | +$76M | |
| 3 | +$73.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.3M |
| 5 |
Goldman Sachs
New York
|
+$43.3M |
Top Sellers
| 1 | -$6.5M | |
| 2 | -$6.12M | |
| 3 | -$1.8M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.17M |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$534K |